الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

physicians total care, inc. - cyclobenzaprine hydrochloride (unii: 0ve05jys2p) (cyclobenzaprine - unii:69o5wqq5ti) - cyclobenzaprine 5 mg - cyclobenzaprine hcl is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. cyclobenzaprine hcl should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. cyclobenzaprine hcl has not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy. hypersensitivity to any component of this product. concomitant use of monoamine oxidase (mao) inhibitors or within 14 days after their discontinuation. hyper

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

unit dose services - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (who group i) in adults to improve exercise ability and delay clinical worsening. the delay in clinical worsening was demonstrated when sildenafil tablets were added to background epoprostenol therapy [see clinical studies (14) ]. studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with new york heart association (nyha) functional class ii-iii symptoms and idiopathic etiology (71%) or associated with connective tissue disease (ctd) (25%). limitation of use: adding sildenafil to bosentan therapy does not result in any beneficial effect on exercise capacity [see clinical studies (14) ]. sildenafil tablets are contraindicated in patients with: • concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions (5.2) ].   • concomitant use of riociguat, a guanylate cyclase s

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

airgas usa, llc - oxygen (unii: s88tt14065) (oxygen - unii:s88tt14065) -

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - sodium zirconium cyclosilicate (unii: d652zwf066) (zirconium cyclosilicate ion - unii:536d9c8st5) - lokelma is indicated for the treatment of hyperkalemia in adults. limitation of use lokelma should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see clinical pharmacology (12.2) and clinical studies (14)] . none. risk summary lokelma is not absorbed systemically following oral administration and maternal use is not expected to result in fetal exposure to the drug. risk summary lokelma is not absorbed systemically following oral administration, and breastfeeding is not expected to result in exposure of the child to lokelma. safety and effectiveness in pediatric patients have not been established. of the total number of subjects in clinical studies of lokelma, 58% were age 65 and over, while 25% were 75 and over. no overall differences in safety or effectiveness were observed between these patients and younger patients.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - baclofen (unii: h789n3fke8) (baclofen - unii:h789n3fke8) - baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. baclofen tablets may also be of some value in patients with spinal cord injuries and other spinal cord diseases.  baclofen tablets are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. the efficacy of baclofen in stroke, cerebral palsy, and parkinson’s disease has not been established and, therefore, it is not recommended for these conditions. hypersensitivity to baclofen.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

zydus lifesciences limited - chlorpromazine hydrochloride (unii: 9wp59609j6) (chlorpromazine - unii:u42b7vya4p) - for the management of manifestations of psychotic disorders. for the treatment of schizophrenia. to control nausea and vomiting. for relief of restlessness and apprehension before surgery. for acute intermittent porphyria. as an adjunct in the treatment of tetanus. to control the manifestations of the manic type of manic-depressive illness. for relief of intractable hiccups. for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability and poor frustration tolerance. do not use in patients with known hypersensitivity to phenothiazines. do not use in comatose states or in the presence of large amounts of central nervous system depr

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

zydus lifesciences limited - teriflunomide (unii: 1c058ikg3b) (teriflunomide - unii:1c058ikg3b) -

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

remedyrepack inc. - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder (mdd). efficacy was established in three short-term (4, 8, and 12 weeks) and two long-term, maintenance trials. venlafaxine hydrochloride extended-release capsules are indicated for the treatment of generalized anxiety disorder (gad). efficacy was established in two 8-week and two 26-week placebo-controlled trials. venlafaxine hydrochloride extended-release capsules, usp are indicated for the treatment of social anxiety disorder (sad), also known as social phobia. efficacy was established in four 12-week and one 26-week, placebo-controlled trials. venlafaxine hydrochloride extended-release capsules are indicated for the treatment of panic disorder (pd), with or without agoraphobia. efficacy was established in two 12-week placebo-controlled trials. hypersensitivity to venlafaxine hydrochloride, desvenlafaxine succinate or to any excipients in the formulation the use of maois (intended to treat psych

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 10 mg - propranolol hydrochloride tablets are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. pr

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

centurion labs, llc - levomefolate magnesium (unii: 1vzz62r081) (levomefolic acid - unii:8s95dh25xc), leucovorin (unii: q573i9dvlp) (leucovorin - unii:q573i9dvlp), flavin adenine dinucleotide (unii: zc44yti8kk) (flavin adenine dinucleotide - unii:zc44yti8kk), flavin mononucleotide (unii: 7n464ure7e) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), cobamami - levomefolate magnesium 1 mg - bump dha™ soft gels are food for special dietary use administered under the supervision of a medical practitioner, for women who are preparing for pregnancy, pregnant or are postnatal. the usual adult dose is one soft gel daily or as directed by a medical professional. if you are pregnant inform your doctor, or if nursing, your child’s doctor that you are using this product. bump dha™ is contraindicated in patients with known hypersensitivity to any of the ingredients.